TC BioPharm (AgeTech UK) Covid-19
Cancer and infectious diseases, gamma delta T cell therapies. Developing safer, less expensive CAR-T products which can target more cancers.
Connections from
Investment Stage:
N/A
Funding Status:
N/A
Headquarters:
United Kingdom
Industry:
UK AgeTech 2020
Number Of Exists:
N/A
Investor Type:
N/A
Technology:
AgeTech Companies
Employee Number:
N/A
Founded Date:
N/A